ORGO: Organogenesis Inc. P/S Multiple

Symbol and logo of brand Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings relies on professional management in regenerative medicine and transparent accounting. The company diversifies risks through the supply of biomaterials for surgery and sports therapy. Business scaling is limited by laboratory capacities and government reimbursement policies. The latest value is recorded as 0.30, which clearly demonstrates the market cap-to-revenue ratio on the chart.

ORGO (Organogenesis Inc.) Price-to-Revenue Ratio history from 07/04/2022 to 11/16/2026

Analytical breakdowns for Organogenesis Holdings Inc. (ORGO)

- market value and analyst target forecast:
Fundamental company analysis:Organogenesis (ORGO)
Manufactured product of Organogenesis

Organogenesis Holdings' status as a leader in regenerative medicine with unique limb-salvage technologies allows the company to command a high market premium. The price-to-sales ratio determines the value of every dollar of commercial revenue, which helps distinguish genuine brand value growth from a speculative bubble amidst P/S volatility when the business's operating margins shift.

Competing companies

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|PNTG: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue NUTX (Nutex Health Corp)|AUNA (Auna Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio sbc-holdings.com SBC|evolus.com - Price-to-Revenue Ratio|Community Health Systems, Inc. - P/S Multiple|SKIN: Price-to-Revenue Ratio|MDWD: P/S Multiple|BTMD: Market Cap to Sales Volume|Market Cap to Revenue JYNT|Price to Sales DocGo Inc. DCGO|PIII (P3 Health Partners, Inc.) - Price-to-Revenue Coefficient|GANX (Gain Therapeutics) - Market Capitalization-to-Revenue Ratio|P/S Multiple EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Price-to-Sales Ratio|CLGN - Price-to-Revenue Ratio|Price to Sales cuprina.com.sg|CCM: P/S Multiple|AMS: Market Cap to Sales Volume|MRM (MEDIROM Corp) - P/S Multiple|ALBT: Market Capitalization-to-Revenue Ratio|P/S Multiple DHAI|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume